Monopar Therapeutics Inc.
MNPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,586 | -$8,402 | -$10,516 | -$9,103 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,141 | $1,898 | $1,641 | $1,468 |
| Change in WC | $3,489 | -$1,354 | $1,646 | $318 |
| Other Non-Cash | $4,552 | $0 | $0 | $0 |
| Operating Cash Flow | -$6,404 | -$7,858 | -$7,229 | -$7,317 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15,324 | -$7,882 | -$4,919 | $0 |
| Inv. Sales/Matur. | $986 | $12,810 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$14,338 | $4,928 | -$4,919 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $59,396 | $2,074 | $109 | $10,925 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$104 | -$47 | -$76 | -$46 |
| Financing Cash Flow | $59,292 | $2,027 | $33 | $10,880 |
| Forex Effect | $0 | -$17 | -$3 | $5 |
| Net Chg. in Cash | $38,550 | -$920 | -$12,118 | $3,567 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,266 | $8,186 | $20,304 | $16,737 |
| End Cash | $45,816 | $7,266 | $8,186 | $20,304 |
| Free Cash Flow | -$6,404 | -$7,858 | -$7,229 | -$7,317 |